HCP, Inc. (NYSE:HCP) registered a -0.14% decrease, still its new closing price is 35.01% up from the company’s 1 year high of 36.37.It posted -1.70% losses in previous 5 sessions and is now the subject of 14 analysts who together assign a hold rating on stock. 2 of Wall Street analysts have an underperform rating; the 0 sells versus 0 buy or better ratings. The 18 stock analysts following this company have an average price target at $30.73, with individual PT in the $28.50-$35.00 range. The shares moved at $29.56, implying that brokerage firms see shares losing about -1.60% in twelve months time.

HCP, Inc. (HCP) SEC Form 4 News

The stock is getting much attention these days as insiders are offloading shares while they posted a -0.54% fall year to date. A Executive Vice President at HCP, Inc. (HCP) offloaded shares in a transaction closed on Wednesday September 07, 2016. Kirby Thomas D sold 3,000 shares in the company at $40.24 each and collected $120,001 in proceeds. Kirby Thomas D now owns 40,481 shares in the company after this transaction. A Executive Vice President in the company, Kowalske Darren A, disclosed a transaction on Wednesday August 31, 2016 that ended up generating $88,000 from the sale of 2,250 shares at $39.2 per share.

HCP, Inc. (NYSE:HCP) Upcoming Results on Tap

HCP, Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $0.49 in that period. Sales during the quarter are predicted to arrive at $595.63 million.

Earnings surprise history: Last quarter, the company posted approximately $654.27 million in revenue and EPS of $0.72. The mean forecast was for $634.8 million and $0.71 a share, respectively. One quarter earlier, revenue for the stock was at $662.18 million, with earnings at $0.74/share.

HCP, Inc. (HCP) Brokerage Update

HCP, Inc. (HCP) is in Goldman’s research list so their analyst rating change is noteworthy. These shares were upgraded to Buy from Neutral by Goldman, according to news reported on Wednesday January 25, 2017.Another important research note was issued by Mizuho on Monday November 21, 2016.The firm upgraded HCP to Buy from Neutral. Over the last six months and over the last three months, the shares of HCP, Inc. (HCP), have changed -14.53% and -6.31%, respectively.